4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-008875
Options or other derivatives
- Executive VP, Research & Dev acquired 287,951 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Williamson Douglas J Executive VP, Research & Dev | 2023-02-10 | Grant or award · Non-Qualified Stock Option (Right to Buy) | +237,296 | 237,296 | D | ||
| Williamson Douglas J Executive VP, Research & Dev | 2023-02-10 | Grant or award · Restricted Stock Units | +50,655 | 50,655 | D | ||
Loading xslF345X03/doc4.xml…